Literature DB >> 26037544

Using the Effects of Youngsters' Eyesight on Quality of Life Questionnaire to Measure Visual Outcomes in Children With Uveitis.

Sheila T Angeles-Han1, Steven Yeh2, Courtney McCracken2, Kirsten Jenkins3, Daneka Stryker2, Erica Myoung2, Larry B Vogler1, Kelly Rouster-Stevens1, Scott R Lambert2, Melanie J Harrison4, Sampath Prahalad1, Carolyn Drews-Botsch5.   

Abstract

OBJECTIVE: The Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) is a novel measure of vision-related quality of life (QOL) and function in children. We aim to determine the validity of the EYE-Q in childhood uveitis.
METHODS: We abstracted medical record data on arthritis and uveitis in a convenience sample of children with juvenile idiopathic arthritis (JIA) and/or uveitis. In addition to the EYE-Q, parents and patients completed questionnaires on overall QOL (Pediatric Quality of Life Inventory [PedsQL]), and physical functioning (Childhood Health Assessment Questionnaire [C-HAQ]).
RESULTS: Among 57 children (8 JIA, 24 JIA and uveitis, 25 uveitis alone), 102 ocular examinations were performed within 1 month of completing questionnaires. Uveitis patients had bilateral disease (69%), anterior involvement (78%), synechiae (51%), and cataracts (49%). Children with vision loss in their better eye (visual acuity [VA] 20/50 or worse) had worse EYE-Q (P = 0.006) and PedsQL (P = 0.028) scores, but not C-HAQ scores. The EYE-Q moderately correlated with logMAR VA (rs  = -0.43), PedsQL (rs  = 0.43), and C-HAQ (rs  = -0.45), but was not correlated with anterior chamber cells or intraocular pressure. The PedsQL and C-HAQ did not correlate with VA or cells. There were strong correlations between the parent and child EYE-Q (rs  = 0.62). Cronbach's α for the child report was 0.91. The EYE-Q had strong test-retest reliability (rs  = 0.75).
CONCLUSION: The EYE-Q may be an important tool in the assessment of visual outcomes in childhood uveitis and an improvement over general measures in detecting changes in vision-related function.
© 2015, American College of Rheumatology.

Entities:  

Mesh:

Year:  2015        PMID: 26037544      PMCID: PMC4624475          DOI: 10.1002/acr.22627

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  29 in total

1.  Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Authors:  Kevin D Frick; Lea T Drye; John H Kempen; James P Dunn; Gary N Holland; Paul Latkany; Narsing A Rao; H Nida Sen; Elizabeth A Sugar; Jennifer E Thorne; Robert C Wang; Janet T Holbrook
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

2.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

Review 3.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

Review 4.  Classification of childhood arthritis: a work in progress.

Authors:  R E Petty
Journal:  Baillieres Clin Rheumatol       Date:  1998-05

5.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

6.  The importance of visual function in the quality of life of children with uveitis.

Authors:  Sheila T Angeles-Han; Kenneth W Griffin; Thomas J A Lehman; John R Rutledge; Stephen Lyman; Joseph T Nguyen; Melanie J Harrison
Journal:  J AAPOS       Date:  2010-03-17       Impact factor: 1.220

7.  The effect of comorbidities upon ocular and systemic health-related quality of life.

Authors:  F J Real; G C Brown; H C Brown; M M Brown
Journal:  Br J Ophthalmol       Date:  2008-04-17       Impact factor: 4.638

8.  Development of an instrument to assess vision-related quality of life in young children.

Authors:  Joost Felius; David R Stager; Priscilla M Berry; Sherry L Fawcett; David R Stager; Solange R Salomão; Adriana Berezovsky; Eileen E Birch
Journal:  Am J Ophthalmol       Date:  2004-09       Impact factor: 5.258

Review 9.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

Review 10.  Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Biologics       Date:  2014-02-15
View more
  17 in total

Review 1.  Uveitis in children.

Authors:  Sheila T Angeles-Han; Consuelo Egla Rabinovich
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

2.  Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.

Authors:  Sheila T Angeles-Han; Mindy S Lo; Lauren A Henderson; Melissa A Lerman; Leslie Abramson; Ashley M Cooper; Miriam F Parsa; Lawrence S Zemel; Tova Ronis; Timothy Beukelman; Erika Cox; H Nida Sen; Gary N Holland; Hermine I Brunner; Andrew Lasky; C Egla Rabinovich
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04       Impact factor: 4.794

3.  Development of Pediatric Eye Questionnaires for Children With Eye Conditions.

Authors:  Sarah R Hatt; David A Leske; Yolanda S Castañeda; Suzanne M Wernimont; Laura Liebermann; Christina S Cheng-Patel; Eileen E Birch; Jonathan M Holmes
Journal:  Am J Ophthalmol       Date:  2019-01-14       Impact factor: 5.258

4.  Comparison of Rating Scales in the Development of Patient-Reported Outcome Measures for Children with Eye Disorders.

Authors:  Sarah R Hatt; David A Leske; Suzanne M Wernimont; Eileen E Birch; Jonathan M Holmes
Journal:  Strabismus       Date:  2017-02-06

Review 5.  Chronic Anterior Uveitis in Children: Psychosocial Challenges for Patients and Their Families.

Authors:  Delana M Parker; Sheila T Angeles-Han; Annette L Stanton; Gary N Holland
Journal:  Am J Ophthalmol       Date:  2018-03-28       Impact factor: 5.258

6.  Visual Function And Quality Of Life In A Cohort Of Swedish Children With Juvenile Idiopathic Arthritis.

Authors:  Rezhna Taha; Maria Papadopoulou; Madeleine Zetterberg; Solveig Oskarsdottir; Marita Andersson Grönlund
Journal:  Clin Ophthalmol       Date:  2019-10-24

7.  Improving quick and accurate diagnosis of childhood JIA-uveitis from a pediatric rheumatology perspective.

Authors:  Jackeline Rodriguez-Smith; Steven Yeh; Sheila Angeles-Han
Journal:  Expert Rev Ophthalmol       Date:  2020-03-12

8.  Comprehensive Assessment of Quality of Life, Functioning, and Mental Health in Children With Juvenile Idiopathic Arthritis and Noninfectious Uveitis.

Authors:  Joseph McDonald; Amy Cassedy; Mekibib Altaye; Jennifer Andringa; Ashley M Cooper; Carolyn Drews-Botsch; George Engelhard; Theresa Hennard; Gary N Holland; Kirsten Jenkins; Scott R Lambert; Jessi Lipscomb; Courtney McCracken; Deborah K McCurdy; Najima Mwase; Sampath Prahalad; Jessica Shantha; Erin Stahl; Virginia Miraldi Utz; A Adrienne Walker; Steven Yeh; Sheila T Angeles-Han
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-06-08       Impact factor: 5.178

9.  Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-02       Impact factor: 3.054

10.  Update on the management of uveitis in children: an overview for the clinician.

Authors:  Lucas Kim; Alexa Li; Sheila Angeles-Han; Steven Yeh; Jessica Shantha
Journal:  Expert Rev Ophthalmol       Date:  2019-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.